FT Options’s Dynavax Technologies DVAX Stock Holding History

FT Options’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-30,795	Closed	-$487K	–	245
2017 Q2	$297K	Buy	+30,795	New	+$200K	0.51%	43
2017 Q1	–	Sell	-15,581	Closed	-$74.9K	–	312
2016 Q4	$62K	Sell	15,581 -11,449	-42%	-$83.9K	0.07%	130
2016 Q3	$284K	Buy	+27,030	New	+$388K	0.23%	85
2016 Q1	–	Sell	-47,248	Closed	-$1.14M	–	305
2015 Q4	$1.14M	Buy	+47,248	New	+$1.18M	0.84%	33

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

FT Options's DVAX Position: Q3 2017 in Review

FT Options sold out of Dynavax Technologies (DVAX) in Q3 2017, closing a stake of 30,795 shares — an estimated $487K sold.

FT Options first reported a position in DVAX in Q4 2015 and held it in 4 quarters. The position peaked at $1.14M in Q4 2015. 119 funds tracked by Wall St. Rank hold DVAX as of Q3 2017.

FT Options reported no remaining Dynavax Technologies position as of Q3 2017 after selling out during the quarter.
FT Options sold 30,795 Dynavax Technologies shares in Q3 2017, an estimated $487K.
FT Options first reported a position in Dynavax Technologies in Q4 2015 and held it in 4 quarters.
FT Options's Dynavax Technologies position peaked at $1.14M in Q4 2015.
119 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.